Antidepressants prevent hierarchy destabilization induced by lipopolysaccharide administration in mice: A neurobiological approach to depression

Annals of the New York Academy of Sciences

Volumn 1262, Issue 1, 2012, Pages 67-73

  Cohn, Daniel Wagner Hamada ^a   Kinoshita, Denise ^a   Palermo Neto, João ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antidepressants; Depression models; Lipopolysaccharide; Social behavior; Social hierarchies

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FLUOXETINE; IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; ILLNESS BEHAVIOR; MALE; MOUSE; NEUROBIOLOGY; NONHUMAN; SEROTONINERGIC SYSTEM; SOCIAL DOMINANCE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS;

EID: 84864139823     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06635.x     Document Type: Article

References (40)

1. Sharp, T. & P.J. Cowen. 2011. 5-HT and depression: is the glass half-full? Curr. Opin. Pharmacol. 11: 45-51.
2. Nestler, E.J. et al. 2002. Neuron 34: 13-25.
3. Mathers, C.D. & D. Loncar. 2006. Projections of global mortality and burden of fDisease from 2002 to 2030. PLoS ONE 3: E442.
4. Krishnan, V. & E.J. Nestler. 2008. The molecular neurobiology of depression. Nature 455: 894-902.
5. Maes, M. et al. 2009. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 24: 27-53.
6. Kirsch, I. et al. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 5: e45.
7. Holmes, P.V. 2003. Rodent models of depression: reexamining validity without anthropomorphic inference. Crit. Rev. Neurobiol. 15: 143-174.
8. Pryce, C.R. & E. Seifritz. 2011. A translational research framework for enhanced validity of mouse models of psychopathological states in depression. Psychoneuroendocrinology 36: 308-329.
9. Woolf, S.H. 2008. The meaning of translational research and why it matters. JAMA 299: 211-213.
10. Dinan, T. 2001. Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis. Hum. Psychopharmacol. 16: 89-93.
11. Cowen, P.J. 2002. Cortisol, serotonin and depression: all stressed out? Br. J. Psychiatry 180: 99-100.
12. Santarelli, L. et al. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
13. Angelucci, F., S. Brene & A.A. Mathe. 2005. BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10: 345-352.
14. Dantzer, R. 2009. Cytokine, sickness behavior, and depression. Immunol. Allergy Clin. North Am. 29: 247-264.
15. Maes, M. 1993. A review on the acute phase response in major depression. Rev. Neurosci. 4: 407-416.
16. Maes, M. 1995. Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 19: 11-38.
17. Schiepers, O.J., M.C. Wichers & M. Maes. 2005. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29: 201-217.
18. Maes, M. et al. 1997. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res. 66: 1-11.
19. Maes, M. et al. 1997. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol. Psychiatry 42: 349-358.
20. Kent, S., R.M. Bluthe, K.W. Kelley & R. Dantzer. 1992. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13: 24-28.
21. Hart, B.L. 1988. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12: 123-137.
22. Dantzer, R. 2001. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N.Y. Acad. Sci. 933: 222-234.
23. Dantzer, R., J.C. O'Connor, G.G. Freund, et al. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9: 46-56.
24. Yirmiya, R. et al. 2001. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24: 531-544.
25. Shen, Y., T.J. Connor, Y. Nolan, et al. 1999. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci. 65: 1773-1786.
26. Dredge, K., T.J. Connor, J.P. Kelly & B.E. Leonard. 1999. Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats. Int. J. Immunopharmacol. 21: 663-673.
27. Castanon, N., J.P. Konsman, C. Medina, et al. 2003. Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation. Psychoneuroendocrinology 28: 19-34.
28. Dunn, A.J. & A.H. Swiergiel. 2001. The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment. Neuroimmunomodulation 9: 163-169.
29. Dunn, A.J. & A.H. Swiergiel. 2005. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 81: 688-693.
30. Dunn, A.J., A.H. Swiergiel & R. de Beaurepaire. 2005. Cytokines as mediators of depression: what can we learn from animal studies? Neurosci. Biobehav. Rev. 29: 891-909.
31. Petit-Demouliere, B., F. Chenu & M. Bourin. 2005. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177: 245-255.
32. Costa-Pinto, F.A., D.W. Cohn, V.M. Sa-Rocha, et al. 2009. Behavior: a relevant tool for brain-immune system interaction studies. Ann. N.Y. Acad. Sci. 1153: 107-119.
33. Cohn, D.W., D. Kinoshita & L.C. Sá-Rocha. 2012. Lipopolysaccharide administration in the dominant mouse destabilizes social hierarchy. Behav. Processes. DOI:
34. Cohn, D.W.H. & L.C. de Sa-Rocha. 2009. Sickness and aggressive behavior in dominant and subordinate mice. Ethology 115: 112-121.
35. Gomes, K.S. et al. 2009. Contrasting effects of acute and chronic treatment with imipramine and fluoxetine on inhibitory avoidance and escape responses in mice exposed to the elevated T-maze. Brain Res. Bull. 78: 323-327.
36. Mason, S.S. et al. 2009. Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur. J. Pharmacol. 602: 306-315.
37. Gray, S., & J.L. Hurst. 1995. The effects of cage cleaning on aggression within groups of male laboratory mice. Anim. Behav 49: 821-826.
38. Palanza, P., L. Gioiosa & S. Parmigiani. 2001. Social stress in mice: gender differences and effects of estrous cycle and social dominance. Physiol. Behav. 73: 411-420.
39. Slattery, D.A., A.L. Hudson & D.J. Nutt. 2004. Invited review: the evolution of antidepressant mechanisms. Fundam. Clin. Pharmacol. 18: 1-21.
40. Aubert, A. 1999. Sickness and behaviour in animals: a motivational perspective. Neurosci. Biobehav. Rev. 23: 1029-1036.